- Home
- LGVN vs FTFT Comparison
LGVN vs FTFT Comparison
Compare LGVN & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- FTFT
- Stock Information
- Founded
- LGVN 2014
- FTFT N/A
- Country
- LGVN United States
- FTFT United States
- Employees
- LGVN N/A
- FTFT N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- FTFT Business Services
- Sector
- LGVN Health Care
- FTFT Consumer Discretionary
- Exchange
- LGVN Nasdaq
- FTFT Nasdaq
- Market Cap
- LGVN 30.0M
- FTFT N/A
- IPO Year
- LGVN 2021
- FTFT N/A
- Fundamental
- Price
- LGVN $2.05
- FTFT $0.34
- Analyst Decision
- LGVN Strong Buy
- FTFT
- Analyst Count
- LGVN 2
- FTFT 0
- Target Price
- LGVN $8.00
- FTFT N/A
- AVG Volume (30 Days)
- LGVN 393.9K
- FTFT 144.5K
- Earning Date
- LGVN 11-08-2024
- FTFT 11-18-2024
- Dividend Yield
- LGVN N/A
- FTFT N/A
- EPS Growth
- LGVN N/A
- FTFT N/A
- EPS
- LGVN N/A
- FTFT N/A
- Revenue
- LGVN $1,229,000.00
- FTFT $37,105,708.00
- Revenue This Year
- LGVN $161.78
- FTFT N/A
- Revenue Next Year
- LGVN $8.62
- FTFT N/A
- P/E Ratio
- LGVN N/A
- FTFT N/A
- Revenue Growth
- LGVN 39.34
- FTFT 84.77
- 52 Week Low
- LGVN $0.77
- FTFT $0.29
- 52 Week High
- LGVN $23.90
- FTFT $2.60
- Technical
- Relative Strength Index (RSI)
- LGVN 52.20
- FTFT 51.19
- Support Level
- LGVN $1.76
- FTFT $0.30
- Resistance Level
- LGVN $2.26
- FTFT $0.36
- Average True Range (ATR)
- LGVN 0.12
- FTFT 0.03
- MACD
- LGVN 0.05
- FTFT 0.00
- Stochastic Oscillator
- LGVN 58.00
- FTFT 58.43
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.